November 2019
Patient Care

A cap patients wear during chemotherapy treatment circulates coolant to chill the scalp to 63 to 67 degrees Fahrenheit, constricting blood vessels to keep chemotherapy drugs from reaching the hair follicles.
Research

Mayo investigators have identified unique practice patterns and prognosis factors in male breast cancer, and associated health disparities. Studies indicate the incidence of breast cancer in males may be on the rise.

A review of patients treated with partial nephrectomy, percutaneous radiofrequency ablation or percutaneous cryoablation for small renal masses found no clinical or statistical difference in five-year outcomes.

Identification of the pathways by which lung adenocarcinoma develops may help specialists determine which patients will benefit from a particular treatment and offer alternatives to patients whose cancer subtypes are unlikely to respond.

Study outcomes support increasing expression of the PD-L1 protein in colorectal cancer cells to improve chemotherapy effectiveness. PD-L1 may be a predictive biomarker for how patients respond to cancer treatment.

A cost-effectiveness study indicates ProtecT trial outcomes actually support the upfront treatment of more-aggressive prostate cancers and the surveillance of less aggressive prostate cancers.

Some patients with follicular lymphoma fare better than others: Researchers found that patients with poor immune responses to follicular lymphoma exhibited a reduction in costimulatory receptors on their T cells.

Education

Jan. 23-25, 2020, in Phoenix
Themes include newly described lesions and rediscovered entities in breast pathology and diagnosis of gastric polyps and early lesions in the stomach, with a focus on diagnostic challenges, molecular updates and emerging issues.

Feb. 7-8, 2020, in Ponte Vedra Beach, Fla.
Topics include imaging, radiation therapy, brain metastases, genomic testing, systemic therapy (including novel immunotherapies and the role of the immune system in managing breast cancer) and symptom management for survivors.

Feb.13-15, 2020, in Scottsdale, Ariz.
Review the current state of knowledge of common cardiovascular complications in patients with cancer, such as heart failure, myocardial ischemia, hypertension, thromboembolism and arrhythmia associated with frequently used anti-cancer medications.

In the Video Center

Travis E. Grotz, M.D., discusses gastric cancer risks, signs and symptoms, diagnosis, and staging, plus treatments including hyperthermic intraperitoneal chemotherapy (HIPEC) and immunotherapy.

Consults and Referrals

877-673-2739 (toll-free)

855-375-9686 (toll-free)

855-995-1503 (toll-free)

Connect With Us
Receive real-time news and thought-leading insight
Mayo Clinic

13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905